IQVIA Tops Q2 Forecasts and Lifts Full-Year Outlook on Record R&D Bookings
IQV sits 51% above its 52-week low of $154.5.
Summary
IQVIA posted Q2 2026 revenue of $4.37 billion and Adjusted Diluted EPS of $3.15, both above the high end of guidance, and raised its full-year outlook. R&D net new bookings hit a record $3.15 billion, up 19% year-over-year.
Key Events · Earnings and Guidance · IQV
-
Q2 Revenue and EPS Beat
Revenue of $4,368 million grew 8.7% year-over-year, and Adjusted Diluted EPS of $3.15 rose 12.1%, exceeding the high end of management's expectations.
-
Record R&D Bookings
R&D Solutions net new bookings reached $3.15 billion, a 19% increase year-over-year, yielding a 1.22x book-to-bill ratio and a contracted backlog of $34.2 billion.
-
Full-Year Guidance Raised
Management lifted 2026 guidance: revenue to $17,275–$17,475 million (midpoint growth 6.5% vs. prior 5.8%), Adjusted EBITDA to $4,000–$4,050 million, and Adjusted Diluted EPS to $12.80–$13.00.
-
Share Repurchases Continue
The company repurchased $398 million of stock in Q2, bringing first-half repurchases to $950 million; $2,819 million remains under the board-authorized program.
Analysis · IQV · Industrial Applications And Services
A strong second quarter saw IQVIA exceed the top end of its own projections for revenue, Adjusted EBITDA, and Adjusted Diluted EPS. The highlight is R&D Solutions net new bookings of $3.15 billion — a 19% surge and a 1.22x book-to-bill ratio — pointing to robust demand and an expanding backlog that underpins sustained revenue growth. Reflecting higher organic growth and M&A contributions, management raised full-year guidance, pushing the revenue growth midpoint to 6.5% from 5.8%. During the quarter the company also repurchased $398 million in stock, bringing the first-half total to $950 million, with $2.8 billion remaining under its authorization. This mix of operational outperformance, a record bookings pipeline, and aggressive capital return underscores confidence in the business trajectory.
How filings like this one have moved
In the 30 days to Sep 13, 2026, 35.6% of the 1216 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, IQV was trading at $234.00 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $35.6B. The 52-week trading range was $154.50 to $247.05. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.